New Oxygen Partners with Peninsula Medical to Advance Authenticity and Standardization in the Anti-Aging Aesthetic Market

Aging is an immutable natural law for humans, yet modern individuals refuse to accept this fate. The transformation of medical aesthetic technologies is empowering the fight against aging, with a growing number of beauty seekers aligning themselves with technology-driven anti-aging solutions.

Why Has Medical Aesthetics Technology Garnered So Much Attention? A Set of Data Tells the Story.

According to the “2021 White Paper on the Medical Aesthetics Industry” released by New Oxygen Data Research Institute, the rapid development of the non-surgical medical aesthetics market became the main theme in 2021. In 2021, the non-surgical consumer market accounted for 49.2% of the entire medical aesthetics market, among which energy-based device procedures were the most popular category in non-surgical consumption, accounting for 21%. It is understood that energy-based device procedures are highly sought after by users due to their more efficient and direct effects in anti-aging medical aesthetics; therefore, energy-based technologies are becoming an “essential tool” for medical aesthetics practitioners.

Data sources: CITIC Securities, iResearch, and New Oxygen Data Research Institute

When it comes to photoelectric anti-aging, one cannot overlook ultrasound-based anti-aging, a photoelectric technology that has been developed in the medical aesthetics industry for over a decade.

Simply put, ultrasound scalpel technology utilizes the principle of focused sound waves to stimulate contraction of the fascia in the SMAS (Superficial Musculoaponeurotic System) layer, promoting endogenous collagen regeneration to achieve lifting, tightening, and volumizing effects. This mechanism is widely recognized within the industry.

However, the awkward reality is that most ultrasonic scalpel devices currently available in the domestic market are imported from abroad and have not obtained certification from the NMPA (National Medical Products Administration). Some of these devices are even counterfeit instruments with no safety assurances. In other words, such uncertified and counterfeit devices are not permitted for use in the market.

Currently, the only device of this kind certified by the National Medical Products Administration (NMPA) is the Peninsula Ultrasound Cannon launched by Peninsula Medical. Since its market debut in August 2021, the Peninsula Ultrasound Cannon has become a highly sought-after treatment in China’s medical aesthetics market. According to data from Yimei Cha, more than 300 institutions on the So-Young platform are currently certified by Peninsula Medical, with the Peninsula Ultrasound Cannon procedure being one of the most popular offerings among these certified providers. However, due to its relatively short time on the market, domestic equipment supply still fails to meet market demand.

This situation also presents numerous challenges to the market: the continuously growing consumer demand has led some medical aesthetic clinics to take reckless actions by using uncertified devices in violation of regulations, which has disrupted the market environment to a certain extent. Furthermore, consumers who are new to photoelectric anti-aging treatments often face safety risks due to their inability to accurately verify the authenticity of the equipment.

Users demand safety, institutions seek profitability, and the market has needs, yet market supply has failed to deliver. To ensure that the benefits of authentic devices reach all stakeholders, New Oxygen is striving to restore the broken links in the market supply chain.

In response, New Oxygen has leveraged its platform advantages in authentic products to launch a collaborative initiative for Peninsula Ultrasonic Cannon devices with qualified medical aesthetic institutions. The program has initially been rolled out simultaneously in Beijing and Hangzhou and is gradually expanding nationwide.

According to data from the New Oxygen Data Yanjiuyuan, from November 2021 to January 2022, the share of Peninsula Ultrasonic Cannon procedures among photoelectric facial anti-aging treatments on the New Oxygen platform in Beijing and Hangzhou continued to rise, reaching 9.98%, 14.96%, and 18.00%, respectively. Benefiting from New Oxygen’s partnership with Peninsula for authentic equipment, searches for “Peninsula Ultrasonic Cannon” also peaked in January 2022.

From a market perspective, this move accurately addresses the pain points in market supply. For a market with strong demand for authentic devices, it is undoubtedly a timely assistance. Meanwhile, the widespread deployment of authentic devices helps foster a healthy competitive landscape based on survival of the fittest, thereby guiding the medical aesthetics industry toward healthy and stable development.

Notably, this equipment collaboration initiative will provide enhanced assurance for device certification. It is reported that Peninsula Ultrasound Cannon projects launched by institutions on New Oxygen during the partnership period will receive the “Genuine Product Treasure” certification mark. Furthermore, users can verify product authenticity through Peninsula Medical’s official channels, offering consumers greater convenience in confirming genuine products. In addition, New Oxygen will provide professional trainers to offer on-site operational guidance, thereby reducing the effort and costs incurred by institutions in equipment operation, management, and maintenance.

In response, New Oxygen stated that providing authentic products is the cornerstone of medical aesthetic services. Moving forward, New Oxygen will focus on market demands and collaborate with more manufacturers of authentic products to extend the availability of genuine supplies to more institutions, thereby offering users safer and more secure medical aesthetic services.